<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Brugada Criteria for SVT with Aberrancy vs VT</h1><div class="card"><div class="card__meta"><div><strong>Author: </strong>Michelle Lin, MD</div><div><strong>Updated:</strong> <!-- -->2/27/2013</div></div><div class="card__content"><h1 id="brugada-criteria-for-svt-with-aberrancy-vs-vt">Brugada Criteria for SVT with Aberrancy vs VT</h1>
<p>Use this sequential 4-question approach to determine if the ECG reveals SVT with aberrancy vs ventricular tachycardia</p>
<p><strong>If you answer YES to any of these questions, it is ventricular tachycardia.</strong></p>
<ol>
<li>Is there an ABSENCE of RS complex in all precordial leads (V1-V6?)</li>
<li>Is the R to S interval &gt;100 msec (2.5 boxes) in one precordial lead?</li>
<li>Is there atrioventricular (AV) dissociation?</li>
<li>Is there morphology criteria for VT?</li>
</ol>
<h2 id="1-is-there-an-absence-of-rs-complex-in-all-precordial-leads-v1-v6-">1. Is there an ABSENCE of RS complex in all precordial leads (V1-V6?)</h2>
<ul>
<li><strong>YES:</strong> VT diagnosis (Sensitivity 21%, Specificity 100%)</li>
<li><strong>NO:</strong> Move to Question 2</li>
</ul>
<p><img src="https://aliemcards.netlify.com/media/brugada-vs-svt_image-1.png" alt="Example of an RS complex"></p>
<h2 id="2-is-the-r-to-s-interval-100-msec-2-5-boxes-in-one-precordial-lead-">2. Is the R to S interval &gt; 100 msec (2.5 boxes) in one precordial lead?</h2>
<ul>
<li><strong>YES:</strong> VT diagnosis (Sensitivity 66%, Specificity 98%)</li>
<li><strong>NO:</strong> Move to Question 3</li>
</ul>
<p><img src="https://aliemcards.netlify.com/media/brugada-vs-svt_image-2.png" alt="Example of how to measure the R-S interval"></p>
<h2 id="3-is-there-atrioventricular-av-dissociation-">3. Is there Atrioventricular (AV) dissociation?</h2>
<ul>
<li><strong>YES:</strong> VT diagnosis (Sensitivity 82%, Specificity 98%)</li>
<li>*<em>NO: *</em>Move to Question 4</li>
</ul>
<p><img src="https://aliemcards.netlify.com/media/brugada-vs-svt_image-3.png" alt="Example of AV dissociation"></p>
<h2 id="4-is-there-morphology-criteria-for-vt-">4. Is there morphology criteria for VT?</h2>
<p>Determine if you have a LBBB morphology (dominant S wave in V1) or a RBBB morphology (dominant R wave in V1) then use the appropriate section below to help differentiate. Is there morphology criteria for VT?</p>
<ul>
<li><strong>YES:</strong> VT diagnosis (Sensitivity 98.7%, Specificity 96.5%)</li>
<li><strong>NO:</strong> SVT with aberrance (Sensitivity 96.5%, Specificity 98.7%)</li>
</ul>
<p><img src="https://aliemcards.netlify.com/media/brugada-vs-svt_image-4.png" alt="Examples of LBBB and RBBB morphologies"></p>
<h2 id="dr-stephen-smith-s-expert-review">Dr. Stephen Smith&#39;s Expert Review</h2>
<p>Validations of the Brugada method have not had very good results.</p>
<p>Here is a <a href="https://www.ncbi.nlm.nih.gov/pubmed/10917326">paper by Isenhour et al</a> that had, for Emergency Physician (EP) #1, a sensitivity of 83% (95% CI = 78% to 91%) and a specificity of 43% (95% CI = 25% to 59%), while EP #2 attained 79% (95% CI = 73% to 87%) and 70% (95% CI = 51% to 84%). </p>
<p>Verekei has subsequently published 2 criteria which are much easier to apply and performed better than the Brugada criteria: </p>
<ol>
<li><a href="https://academic.oup.com/eurheartj/article/28/5/589/2887583/Application-of-a-new-algorithm-in-the-differential">Heart Journal 2007</a>: Still a bit complex</li>
<li><a href="https://www.ncbi.nlm.nih.gov/pubmed/18180024">Heart Rhythm 2008</a>: Uses aVR only</li>
</ol>
<p>I have a <a href="http://hqmeded-ecg.blogspot.com/2011/10/wide-complex-tachycardia-ventricular.html">post on differentiating VT and SVT with aberrancy using the Sasaki rule</a>, which has not been validated either, but is even simpler than either Vereckei rule. I use it as a final step if I don’t have the diagnosis from 6 earlier steps. Of course, the diagnosis is not nearly as important as the management, which is easily accomplished by electrical cardioversion.</p>
<h2 id="references">References</h2>
<ul>
<li>Brugada P et al. Circulation. 1991 May;83(5): 1649-59. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/2022022">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"brugada-vs-svt","title":"Brugada Criteria for SVT with Aberrancy vs VT","authors":["Michelle Lin, MD"],"categories":[{"slug":"cardiovascular","name":"Cardiovascular"}],"created":"2013/02/27","updated":null,"body":"\n# Brugada Criteria for SVT with Aberrancy vs VT\n\nUse this sequential 4-question approach to determine if the ECG reveals SVT with aberrancy vs ventricular tachycardia\n\n**If you answer YES to any of these questions, it is ventricular tachycardia.**\n\n1. Is there an ABSENCE of RS complex in all precordial leads (V1-V6?)\n2. Is the R to S interval \u003e100 msec (2.5 boxes) in one precordial lead?\n3. Is there atrioventricular (AV) dissociation?\n4. Is there morphology criteria for VT?\n\n## 1. Is there an ABSENCE of RS complex in all precordial leads (V1-V6?)\n\n- **YES:** VT diagnosis (Sensitivity 21%, Specificity 100%)\n- **NO:** Move to Question 2\n\n![Example of an RS complex](https://aliemcards.netlify.com/media/brugada-vs-svt_image-1.png)\n\n## 2. Is the R to S interval \u003e 100 msec (2.5 boxes) in one precordial lead?\n\n- **YES:** VT diagnosis (Sensitivity 66%, Specificity 98%)\n- **NO:** Move to Question 3\n\n![Example of how to measure the R-S interval](https://aliemcards.netlify.com/media/brugada-vs-svt_image-2.png)\n\n## 3. Is there Atrioventricular (AV) dissociation?\n\n- **YES:** VT diagnosis (Sensitivity 82%, Specificity 98%)\n- **NO: **Move to Question 4\n\n![Example of AV dissociation](https://aliemcards.netlify.com/media/brugada-vs-svt_image-3.png)\n\n## 4. Is there morphology criteria for VT?\n\nDetermine if you have a LBBB morphology (dominant S wave in V1) or a RBBB morphology (dominant R wave in V1) then use the appropriate section below to help differentiate. Is there morphology criteria for VT?\n\n- **YES:** VT diagnosis (Sensitivity 98.7%, Specificity 96.5%)\n- **NO:** SVT with aberrance (Sensitivity 96.5%, Specificity 98.7%)\n\n![Examples of LBBB and RBBB morphologies](https://aliemcards.netlify.com/media/brugada-vs-svt_image-4.png)\n\n## Dr. Stephen Smith's Expert Review\n\nValidations of the Brugada method have not had very good results.\n\nHere is a [paper by Isenhour et al](https://www.ncbi.nlm.nih.gov/pubmed/10917326) that had, for Emergency Physician (EP) #1, a sensitivity of 83% (95% CI = 78% to 91%) and a specificity of 43% (95% CI = 25% to 59%), while EP #2 attained 79% (95% CI = 73% to 87%) and 70% (95% CI = 51% to 84%). \n\nVerekei has subsequently published 2 criteria which are much easier to apply and performed better than the Brugada criteria: \n\n1. [Heart Journal 2007](https://academic.oup.com/eurheartj/article/28/5/589/2887583/Application-of-a-new-algorithm-in-the-differential): Still a bit complex\n2. [Heart Rhythm 2008](https://www.ncbi.nlm.nih.gov/pubmed/18180024): Uses aVR only\n\nI have a [post on differentiating VT and SVT with aberrancy using the Sasaki rule](http://hqmeded-ecg.blogspot.com/2011/10/wide-complex-tachycardia-ventricular.html), which has not been validated either, but is even simpler than either Vereckei rule. I use it as a final step if I don’t have the diagnosis from 6 earlier steps. Of course, the diagnosis is not nearly as important as the management, which is easily accomplished by electrical cardioversion.\n\n## References\n\n- Brugada P et al. Circulation. 1991 May;83(5): 1649-59. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/2022022)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"brugada-vs-svt"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>